Clare Pain is a medical journalist who throughout the pandemic was responsible for writing professional publications read by Australian medical professionals to keep them up to date with the science.
In 2020 she started to notice some strange changes to the culture of the medical profession in Australia and spoke out for the retention of classical medical doctrines such as conflict of interest disclosures and medical ethics.
Clare's personal journey includes being laughed at in Australian hospitals in 2020 for wearing too much PPE (masks and gloves) and anxiously awaiting Covid-19 vaccinations, to 2021 in Sheffield, England where she tried - unvaccinated - to catch Covid-19 to acquire immunity.
In this interview we discussed:
Behind the scenes of medical journalism throughout the pandemic
The differences between UK and Australian culture
The Australian ban on Ivermectin
Malfeasance by pharmaceutical companies
A survey she conducted with a sample size of 30,000 measuring vaccine consent
Note: The 25 minute long credits to this interview display raw statements from Clare's survey where Australians shared why they received a C-19 vaccination. The statements on screen are uncensored and do not necessarily represent the views of Discernable or Clare Pain.
Watch the full interview at: https://discernable.io/clare-pain-medical-journalist-writing-for-doctors-throughout-the-pandemic
---------------------
DISCERNABLE
The Video Archive: https://discernable.io
Prefer audio? Search for 'It Is Discernable' on Spotify and Apple Podcasts
Join our Private Community: https://discernable.locals.com
Purchase tickets (and replays) to our Town Halls: https://discernable.io/townhall
CLARITY ON HEALTH SURVEY
https://clarityonhealth.org
Scott Morrison mandate quote
https://www.sbs.com.au/news/article/scott-morrison-says-a-coronavirus-vaccine-would-be-as-mandatory-as-you-can-possibly-make-it/mcg55d7r1
Merck press release on ivermectin
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic
Merck press release on molnupirivir
https://www.merck.com/news/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir
FDA Emergency Use Authorisation rules
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
UK COVID inquiry
https://www.gov.uk/government/publications/uk-covid-19-inquiry-terms-of-reference
25:59
1:53
1:52
1:32
1:48
2:12
1:00
